Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2008-3-3
pubmed:databankReference
pubmed:abstractText
Ziprasidone has been used to treat schizophrenia since 2000. It is unknown whether its modest QTc-prolonging effect increases cardiovascular event risk.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1555-2101
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
69
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
114-21
pubmed:meshHeading
pubmed-meshheading:18312045-Adult, pubmed-meshheading:18312045-Antipsychotic Agents, pubmed-meshheading:18312045-Body Mass Index, pubmed-meshheading:18312045-Dyslipidemias, pubmed-meshheading:18312045-Female, pubmed-meshheading:18312045-Hemoglobin A, Glycosylated, pubmed-meshheading:18312045-Humans, pubmed-meshheading:18312045-Hypertension, pubmed-meshheading:18312045-Long QT Syndrome, pubmed-meshheading:18312045-Male, pubmed-meshheading:18312045-Observation, pubmed-meshheading:18312045-Piperazines, pubmed-meshheading:18312045-Prevalence, pubmed-meshheading:18312045-Questionnaires, pubmed-meshheading:18312045-Research Design, pubmed-meshheading:18312045-Schizophrenia, pubmed-meshheading:18312045-Severity of Illness Index, pubmed-meshheading:18312045-Thiazoles, pubmed-meshheading:18312045-Triglycerides
pubmed:year
2008
pubmed:articleTitle
The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): design and baseline subject characteristics.
pubmed:affiliation
Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6021, USA. bstrom@mail.med.upenn.edu
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study